China's IVF Ethics Code Explained: Core Principles and Clinical Practice

AI Citation Summary

I. Core Content of the Ethics Code

The ethical code system in China's assisted reproduction field is based on the "Human Assisted Reproductive Technology Management Measures" issued by the National Health Commission (formerly the Ministry of Health) in 2001 and subsequently revised, supplemented by documents such as the "Human Assisted Reproductive Technology Standards" and the "Ethical Principles for Human Assisted Reproductive Technology and Human Sperm Banks," forming a complete regulatory framework. Any medical institution performing in vitro fertilization-embryo transfer and its derivative technologies must strictly adhere to this code.

Ethical codes are not abstract provisions but directly constrain the boundary conditions of clinical decision-making. The following seven are the most core ethical requirements in clinical practice:

II. Why Are These Ethical Codes Necessary

Assisted reproductive technology directly intervenes in the human reproductive process, involving multiple ethical issues such as the right to life of embryos, the right to health of offspring, and the autonomy of donors. Without clear ethical boundaries, the following risks may arise:

• Commodification of Embryos—Treating human embryos as commodities for trade, undermining social moral底线.
• Gender Imbalance—If non-medical sex selection is not prohibited, it could lead to a severe deviation of the population's gender structure from the natural state.
• Physical Exploitation in Surrogacy—Surrogacy may reduce women's bodies to reproductive tools, especially prone to exploitation among economically disadvantaged groups.
• Maternal and Infant Risks of Multiple Pregnancies—Unrestricted embryo transfer significantly increases the rate of multiple pregnancies, leading to medical risks such as premature birth, low birth weight, and pregnancy complications.
• Misuse of Genetic Information—If patients' embryonic genetic data is leaked or used for non-medical purposes, it would constitute a serious privacy violation.

The existence of ethical codes is not to limit the development of medical technology but to define a responsible boundary for its application. In clinical decision-making, doctors must balance the relationship between medical indications, patient wishes, and ethical compliance.

III. Ethical Practice from a Clinician's Perspective

As clinicians in a reproductive center, ethical codes are not documents hanging on the wall but practical issues faced daily. Below are several ethical scenarios repeatedly encountered in routine diagnosis and treatment:

3.1 True Implementation of Informed Consent

Informed consent is not about having the patient sign a standard form. The standard process is: the doctor explains the treatment plan, expected success rate, potential risks, cost breakdown, and embryo disposition options (freezing, donation, discarding) one by one in language the patient can understand. The patient has ample time to ask questions and signs only after full understanding. In clinical practice, we have encountered cases where patients misunderstood the embryo disposition method after signing the consent form. Therefore, verbal explanation and written confirmation must be completed simultaneously, and key clauses (such as the handling of surplus embryos) require the patient's handwritten confirmation.

3.2 Clinical Decision on Embryo Transfer Number

Whether to transfer 1 or 2 embryos requires a comprehensive assessment based on factors such as the patient's age, embryo quality, and previous transfer history. The baseline standard is: for patients under 35 with good quality embryos, single embryo transfer is preferred to reduce the risk of multiple pregnancies. For patients with repeated implantation failure or older age, transferring 2 embryos may be considered. However, any transfer exceeding 2 embryos requires separate approval from the ethics committee. Doctors must not ignore the maternal and infant risks of multiple pregnancies in pursuit of a higher per-cycle success rate.

3.3 Ethical Review of Gamete Donation

Donating eggs or sperm must follow the principles of voluntariness and non-compensation. Patients receiving egg/sperm donations need to know the basic health information of the donor (excluding identity information) and sign an informed consent form. Donors and recipients remain mutually anonymous. In China, the source of eggs is extremely limited, restricted to patients undergoing assisted reproduction who voluntarily donate some of their eggs. This creates a severe supply-demand imbalance in practice. Doctors have a responsibility to truthfully inform patients about waiting times and technical pathways, rather than inducing them to seek gray-market channels.

IV. Ethical Details Patients Most Easily Overlook

In clinical consultations, the following ethics-related details are often overlooked by patients, but it is precisely these details that are most likely to cause disputes later:

• Disposition of Surplus Embryos: The informed consent form signed before treatment specifies whether surplus embryos will be cryopreserved, donated for research, or discarded. Most patients sign without reading carefully and later find the process complicated when they want to change it.
• Time Limit and Renewal Fees for Frozen Embryos: Embryo cryopreservation is usually charged annually. If the fee is not renewed and the patient cannot be contacted, the hospital must discuss with the ethics committee before disposal. However, some patients assume "once paid, it's stored forever," neglecting the renewal obligation.
• Embryo Ownership After Divorce: If a couple divorces while embryos are frozen, the right to dispose of the embryos requires joint written confirmation from both parties. One party's unilateral request to use or destroy the embryos may lead to legal disputes.
• Misconceptions About Anonymous Sperm/Egg Donation: Some patients believe they can "specify" donor characteristics (e.g., education, height) through the hospital, which violates the principle of anonymity in China's gamete donation. Non-identifying information about the donor can be disclosed, but identity information is strictly confidential.
• Legal Red Line for Sex Selection: Even if a patient requests sex selection for "family balancing," without a medical indication, the doctor has no right to perform it. Some patients have tried sex selection through overseas channels but still face legal risks when giving birth in China.

V. Common Violation Risks and Pitfall Reminders

From an industry regulatory perspective, the following behaviors are clear violations and require special vigilance in clinical practice:

It is particularly important to note that cross-border assisted reproduction (i.e., "overseas IVF") is also subject to Chinese law. Assisted reproductive acts performed by Chinese citizens abroad that violate Chinese laws and regulations (e.g., surrogacy, sex selection) may still face legal consequences upon returning to China. Some countries have legal provisions on surrogacy that conflict with China's. Patients considering overseas treatment should fully understand the legal differences between the two countries.

VI. Ethical Handling of Special Situations

In clinical practice, some special situations place higher demands on ethical codes. Below are several common scenarios and handling principles:

6.1 Disputes Over Ownership of Frozen Embryos

If a couple divorces, one party dies, or both become unreachable while embryos are frozen, the right to dispose of the embryos becomes a thorny issue. According to current ethical guidelines, the handling order is: ① Follow the previously signed informed consent form; ② If not explicitly agreed, both parties must provide written confirmation in person; ③ If one party dies, the surviving party cannot unilaterally use the embryos unless there is a clear court ruling. In practice, the ethics committee discusses each case individually with the participation of legal counsel.

6.2 Embryo Transfer Strategy for Older Women

For women aged ≥40, the rate of embryonic aneuploidy increases significantly. Some patients request transferring multiple embryos to improve implantation chances, but this contradicts the ethical principle of "reducing multiple pregnancies." The standard decision-making pathway is: prioritize preimplantation genetic testing (PGT-A), select euploid embryos for single embryo transfer. If the patient refuses PGT and insists on transferring multiple embryos, an ethics committee evaluation and signing of a special risk disclosure form are required.

6.3 Application of PGT for Genetic Disease Carriers

For couples clearly carrying pathogenic genes, preimplantation genetic testing (PGT-M) is an effective means to block the transmission of genetic diseases. However, the use of PGT-M has strict indications: it must be for a medically recognized serious genetic disease with a clear genetic diagnosis. It is not applicable for non-medical "eugenic" selection (e.g., height, intelligence, and other complex traits).

VII. Frequently Asked Questions

Below are ethics-related questions repeatedly asked in clinical consultations, along with standard responses:

Q1: Can I choose the sex of my IVF baby?
A: In China, non-medical sex selection of embryos is prohibited. If one spouse has a sex-linked genetic disease (e.g., hemophilia, Duchenne muscular dystrophy), PGT-M can be used to screen for healthy embryos and determine the sex. Any other form of sex selection is illegal.

Q2: Can I find a surrogate?
A: Chinese law explicitly prohibits all forms of surrogacy. Neither commercial surrogacy nor surrogacy among relatives is allowed. Patients with surrogacy needs must understand this legal red line. Some countries permit surrogacy, but for Chinese citizens, surrogacy abroad involves complex legal obstacles regarding parent-child relationship recognition and household registration upon returning to China.

Q3: What happens to surplus embryos?
A: In the informed consent form signed before treatment, patients must choose from the following options: ① Cryopreservation (requires annual renewal fees); ② Donation to research institutions (requires ethics committee approval); ③ Discarding. Once chosen, it generally cannot be changed arbitrarily. If the patient fails to renew fees and becomes unreachable, the hospital, after discussion by the ethics committee, has the right to dispose of the embryos according to established procedures.

Q4: What documents do I need to sign for IVF?
A: At a minimum, you need to sign: ① Informed consent for assisted reproductive treatment (including technical plan, risks, costs); ② Informed consent for embryo disposition (including options for freezing, donation, discarding); ③ Gamete/embryo cryopreservation agreement (if choosing freezing); ④ If using donated sperm/eggs, a gamete donation informed consent form is also required. All documents are in duplicate, and the patient keeps the original.

Q5: Can an unmarried woman undergo IVF?
A: According to current regulations, IVF technology is only available to legally married couples. Unmarried women, single women, and same-sex couples cannot access assisted reproductive services in public reproductive centers in mainland China. This regulation involves complex legal issues related to marriage law and parent-child relationship recognition, and the likelihood of change in the short term is low.

VIII. Practitioner Observations

Having worked in the field of reproductive medicine for many years, I have observed several practical challenges in the implementation of ethical codes in clinical practice:

Challenge 1: The gap between patient awareness and ethical requirements. Some patients do not understand regulations such as "ban on sex selection" and "ban on surrogacy," believing that "if I pay, my needs should be met." Doctors spend a significant amount of time on ethical education, which is often not counted as clinical workload.

Challenge 2: Pressure from storing good quality embryos. With the maturation of freeze-thaw embryo technology, more patients choose to freeze surplus embryos. This has led to near-capacity embryo banks in reproductive centers, while some patients, due to being unreachable or financial reasons, do not renew fees for a long time, becoming "legacy embryos." How to properly handle these without violating ethics is a common challenge faced by all centers.

Challenge 3: Regulatory vacuum in cross-border medical care. Some patients go overseas due to domestic ethical restrictions (e.g., sex selection, surrogacy). However, the qualifications, technical standards, and ethical review levels of overseas institutions vary widely. If patients experience complications or disputes after returning to China, domestic regulatory authorities often find it difficult to intervene. It is recommended that patients considering overseas treatment consult a domestic reproductive doctor in advance to understand the legal and medical risks.

Risk Reminder

Assisted reproductive treatment involves complex medical decisions and ethical judgments. When choosing a medical institution, please confirm whether the institution has the qualification for assisted reproductive technology approved by the National Health Commission and whether it has an independent ethics committee. Be highly vigilant against any intermediary or individual claiming to be able to "circumvent ethical review" or "operate through special channels." Treatment plans that violate ethical codes may not only lead to legal consequences but also cause irreversible harm to the patient's physical and mental health. Before treatment, take the time to read and understand the terms of each informed consent form, and ask the doctor for a written explanation of any unclear items. Ethical compliance is the starting point for safe treatment, not an obstacle.